Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients

BACKGROUND: Currently, no clearly superior management strategy exists for recurrent, platinum-resistant ovarian cancer. We tested the efficacy and safety of gemcitabine combined with oxaliplatin (GEMOX) in a multicentre phase II clinical trial. METHODS: Forty one patients with recurrent, platinum-re...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Vici, Patrizia, Sergi, Domenico, Pizzuti, Laura, Mariani, Luciano, Arena, Maria Grazia, Barba, Maddalena, Maugeri-Saccà, Marcello, Vincenzoni, Cristina, Vizza, Enrico, Corrado, Giacomo, Paoletti, Giancarlo, Tomao, Federica, Tomao, Silverio, Giannarelli, Diana, Di Lauro, Luigi
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3750635/
https://ncbi.nlm.nih.gov/pubmed/23927758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-32-49
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki